Atkins Michael B. 4
4 · Werewolf Therapeutics, Inc. · Filed May 24, 2024
Insider Transaction Report
Form 4
Atkins Michael B.
Director
Transactions
- Award
Stock Option (right to buy)
2024-05-24+6,723→ 6,723 totalExercise: $4.88Exp: 2034-05-23→ Common Stock (6,723 underlying)
Footnotes (1)
- [F1]The option was granted on May 24, 2024. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders following the grant date, subject to the reporting person's continued service as a director.